Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: Regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1

Oncogene

Volumn 25, Issue 13, 2006, Pages 1943-1954

  Walker, G E ^a,c   Antoniono, R J ^a   Ross, H J ^b   Paisley, T E ^d   Oh, Y ^a,d,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b EARLE A CHILES RESEARCH INSTITUTE   (United States)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

25.1; cAMP; Lung cancer; mac25 IGFBP rP1; NE differentiation; NSCLC

Indexed keywords

CYCLIC AMP; GROWTH FACTOR; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 1; ISOBUTYLMETHYLXANTHINE; PROTEIN; PROTEIN 25.1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LUNG NEOPLASMS; NERVE TISSUE PROTEINS; NEUROENDOCRINE TUMORS;

EID: 33645275710     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209213     Document Type: Article

References (41)

1. Ahmed S, Yamamoto K, Sato Y, Ogawa T, Herrmann A, Higashi S et al. (2003). Biochem Biophys Res Commun 310: 612-618.
2. Akaogi K, Okabe Y, Funahashi K, Yoshitake Y, Nishikawa K, Yasumitsu H et al. (1994). Biochem Biophys Res Commun 198: 1046-1053.
3. Akaogi K, Sato J, Okabe Y, Sakamoto Y, Yasumitsu H, Miyazaki K. (1996). Cell Growth Differ 7: 1671-1677.
4. Berendsen HH, de Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ et al. (1989). J Clin Oncol 7: 1614-1620.
5. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M et al. (1998). Oncogene 16: 2459-2467.
6. Carnaghi C, Rimassa L, Garassino I, Santoro A. (2001). Ann Oncol 12(Suppl 2): S119-S123.
7. Cersosimo RJ. (2002). Am J Health Syst Pharm 59: 611-642.
8. Chen T, Cho RW, Stork PJ, Weber MJ. (1999). Cancer Res 59: 213-218.
9. Cox ME, Deeble PD, Bissonette EA, Parsons SJ. (2000). J Biol Chem 275: 13812-13818.
10. Deeble PD, Murphy DJ, Parsons SJ, Cox ME. (2001). Mol Cell Biol 21: 8471-8482.
11. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). Proc Natl Acad Sci USA 92: 9363-9367.
12. Gajra A, Tatum AH, Newman N, Gamble GP, Lichtenstein S, Rooney MT et al. (2002). Lung Cancer 36: 159-165.
13. Gazdar AF, Helman LJ, Israel MA, Russell EK, Linnoila RI, Mulshine JL et al. (1988). Cancer Res 48: 4078-4082.
14. Gosney JR, Gosney MA, Lye M, Butt SA. (1995). Thorax 50: 116-120.
15. Graziano SL, Tatum A, Herdon II JE, Box J, Memoli V, Green MR et al. (2001). Lung Cancer 33: 115-123.
16. Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ et al. (1994). Cancer Res 54: 2908-2913.
17. Haugk KL, Wilson HM, Swisshelm K, Quinn LS. (2000). Endocrinology 141: 100-110.
18. Heasley LE. (2001). Oncogene 20: 1563-1569.
19. Hwa V, Oh Y, Rosenfeld RG. (1999). Endocr Rev 20: 761-787.
20. Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Baba M, Fujisawa T et al. (2001). Cancer 92: 1108-1112.
21. Jiang SX, Kameya T, Sato Y, Yanase N, Yoshimura H, Kodama T. (1996). Am J Pathol 148: 837-846.
22. Jiang SX, Kameya T, Shinada J, Yoshimura H. (1999). Mod Pathol 12: 362-369.
23. Jull BA, Plummer III HK, Schuller HM. (2001). J Cancer Res Clin Oncol 127: 707-717.
24. Linnoila RI, Piantadosi S, Ruckdeschel JC. (1994). Chest 106(6 Suppl): 367S-371S.
25. Lopez-Bermejo A, Buckway CK, Devi GR, Hwa V, Plymate SR, Oh Y et al. (2000). Endocrinology 141: 4072-4080.
26. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. (1993). Cell Growth Differ 4: 715-722.
27. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG. (1996). J Biol Chem 271: 30322-30325.
28. Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A et al. (2003). Cancer 97: 2487-2497.
29. Reynolds SD, Hong KU, Giangreco A, Mango GW, Guron C, Morimoto Y et al. (2000). Am J Physiol Lung Cell Mol Physiol 278: L1256-L1263.
30. Schleusener JT, Tazelaar HD, Jung SH, Cha SS, Cera PJ, Myers JL et al. (1996). Cancer 77: 1284-1291.
31. Shaw GL, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Johnson BE et al. (1993). Cancer Res 53: 5181-5187.
32. Skov BG, Sorensen JB, Hirsch FR, Larsson LI, Hansen HH. (1991). Ann Oncol 2: 355-360.
33. Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR. (1999). Cancer Res 59: 2370-2375.
34. Swisshelm K, Ryan K, Tsuchiya K, Sager R. (1995). Proc Natl Acad Sci USA 92: 4472-4476.
35. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. (2001). J Biol Chem 276: 39264-39270.
36. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ. (1997). Cell 89: 73-82.
37. Wallace WAH. (2002). Eur J Surg Oncol 28: 63-66.
38. Wilson EM, Oh Y, Hwa V, Rosenfeld RG. (2001). J Clin Endocrinol Metab 86: 4504-4511.
39. Wilson EM, Oh Y, Rosenfeld RG. (1997). J Clin Endocrinol Metab 82: 1301-1303.
40. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H. (1994). Biochem J 303(Part 2): 591-598.
41. Yesner R. (2001). Exp Mol Path 70: 179-182.